8.22
price up icon2.69%   0.215
after-market Handel nachbörslich: 8.06 -0.16 -1.95%
loading

Cervomed Inc Aktie (CRVO) Neueste Nachrichten

pulisher
07:03 AM

Will CervoMed Inc. outperform the market2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com

07:03 AM
pulisher
04:53 AM

Trend analysis for CervoMed Inc. this weekJuly 2025 Movers & Safe Capital Investment Plans - newser.com

04:53 AM
pulisher
03:43 AM

Will CervoMed Inc. stock reach all time highs in 2025Dividend Hike & Low Drawdown Trading Strategies - newser.com

03:43 AM
pulisher
02:22 AM

How to interpret RSI for CervoMed Inc. stockPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com

02:22 AM
pulisher
01:49 AM

Will CervoMed Inc. (DP8) stock keep high P E multiplesJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com

01:49 AM
pulisher
01:42 AM

Custom watchlist performance reports with CervoMed Inc.Portfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com

01:42 AM
pulisher
Oct 13, 2025

Is CervoMed Inc. a candidate for recovery playQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Statistical indicators supporting CervoMed Inc.’s strengthJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Analyzing recovery setups for CervoMed Inc. investors2025 Risk Factors & AI Based Trade Execution Alerts - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

What to do if you’re stuck in CervoMed Inc.2025 Momentum Check & Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Does CervoMed Inc. stock trade at a discount to peersIPO Watch & Advanced Swing Trade Entry Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using data tools to time your CervoMed Inc. exitJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Advanced analytics toolkit walkthrough for CervoMed Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

CervoMed (NASDAQ:CRVO) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Why CervoMed Inc. stock is rated strong buyShare Buyback & Low Drawdown Momentum Ideas - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

CervoMed Unveils Promising Phase 2b Trial Results - TipRanks

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed Drug Cut Dementia Progression Risk By 75% In Trial - inkl

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed shares jump after strong results in dementia drug trial - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed stock jumps after new positive dementia drug results - Business Upturn

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed stock soars after positive dementia treatment trial data - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed Says Neflamapimod Shows Effective in Treating Dementia with Lewy Bodies Without Alzheimer's Overlap - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed (CRVO) Reveals Promising Phase 2b Trial Data for Dement - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed rises after dementia drug shows promise in mid-stage study - TradingView

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed Inc. Reports Promising Phase 2b Trial Results for Neflamapimod in Dementia with Lewy Bodies - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 08, 2025

1.12‑pt CDR‑SB gain; 50% GFAP drop — CervoMed Phase 2b RewinD‑LB data show clinical–biomarker correlation - Stock Titan

Oct 08, 2025
pulisher
Oct 08, 2025

CervoMed appoints Matthew Winton as chief commercial and business officer By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 07, 2025

CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer - GlobeNewswire

Oct 07, 2025
pulisher
Oct 07, 2025

CervoMed Inc. Appoints Matthew Winton as Chief Commercial and Business Officer - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

CervoMed appoints Matthew Winton as chief commercial and business officer - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

CervoMed appoints Matthew Winton, Ph.D., as chief commercial and business officer - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

75K-option grant: CervoMed names Matthew Winton Chief Commercial & Business Officer, readies for Phase 3 - Stock Titan

Oct 07, 2025
pulisher
Oct 07, 2025

CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - Sahm

Oct 07, 2025
pulisher
Oct 06, 2025

Applying chart zones and confluence areas to CervoMed Inc.Trade Volume Summary & Daily Chart Pattern Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will CervoMed Inc. stock go up soon2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Short Interest in CervoMed Inc. (NASDAQ:CRVO) Decreases By 31.7% - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

What drives CervoMed Inc stock priceEarnings Revision Updates & Free Stock Education Platform for New Investors - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

How CervoMed Inc. (DP8) stock compares with market leaders2025 Trade Ideas & Consistent Growth Equity Picks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can a trend reversal in CervoMed Inc. lead to recoveryJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is CervoMed Inc. stock a buy in volatile markets2025 Dividend Review & Short-Term High Return Ideas - newser.com

Oct 05, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):